BRAF Comp. Subsequent Testing (2 CNA) (dog)

LABOKLIN Service ID: 517

Indications:

  • Urothelial carcinoma (transitional cell carcinoma) after negative BRAF mutation analysis (V595E).

Material

  • urinary sediment (especially early morning urine; fluid + smear)
  • aspiration cytology (smears)
  • formalin-fixed, paraffin-embedded tissue (from previous histological examination)

Method

copy number alteration (CNA)

Species list

dog

Duration

2 - 7 days

Remark

Detection of the copy number alterations (CNAs) 13/19 and 36/19.
Only a positive result is conclusive.
Reasons for negative results:

  • It is not a urothelial (transitional cell) carcinoma.
  • The urothelial (transitional cell) carcinoma is not caused by BRAF mutation or the CNAs 13/19 and 36/19.
  • There were no or too few relevant cells in the sample.
  • There is a marked inflammation.


  • The test for CNAs is not suitable for prostate carcinomas.
  • The test cannot be used for cats.